102 related articles for article (PubMed ID: 23648194)
1. Platelet rich plasma.
Banfi G
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):1. PubMed ID: 23648194
[No Abstract] [Full Text] [Related]
2. Applications and limits of platelet-rich plasma in sports related injuries.
Stanco D; Vigano' M; Croiset SJ; De Girolamo L
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):53S-61S. PubMed ID: 23648199
[TBL] [Abstract][Full Text] [Related]
3. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
[TBL] [Abstract][Full Text] [Related]
4. Growth factor confusion.
Dines JS
Arthroscopy; 2010 Sep; 26(9):1144; author reply 1145-6. PubMed ID: 20810068
[No Abstract] [Full Text] [Related]
5. Concentration of platelets and growth factors in canine autologous conditioned plasma.
Stief M; Gottschalk J; Ionita JC; Einspanier A; Oechtering G; Böttcher P
Vet Comp Orthop Traumatol; 2011; 24(2):122-5. PubMed ID: 21225088
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma. A review.
Rodrigues SV; Acharya AB; Thakur SL
N Y State Dent J; 2012 Jan; 78(1):26-30. PubMed ID: 22474794
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich plasma: a review of the science and possible clinical applications.
Mehta V
Orthopedics; 2010 Feb; 33(2):111. PubMed ID: 20187590
[No Abstract] [Full Text] [Related]
8. Platelet-rich plasma.
Saucedo JM; Yaffe MA; Berschback JC; Hsu WK; Kalainov DM
J Hand Surg Am; 2012 Mar; 37(3):587-9; quiz 590. PubMed ID: 22305737
[No Abstract] [Full Text] [Related]
9. Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems.
Kaux JF; Le Goff C; Renouf J; Peters P; Lutteri L; Gothot A; Crielaard JM
Pathol Biol (Paris); 2011 Oct; 59(5):275-7. PubMed ID: 21145177
[TBL] [Abstract][Full Text] [Related]
10. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
Sundman EA; Cole BJ; Fortier LA
Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
[TBL] [Abstract][Full Text] [Related]
11. Platelet-rich plasma concentrate to augment bone fusion.
Bibbo C; Hatfield PS
Foot Ankle Clin; 2010 Dec; 15(4):641-9. PubMed ID: 21056862
[TBL] [Abstract][Full Text] [Related]
12. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.
Alsousou J; Thompson M; Hulley P; Noble A; Willett K
J Bone Joint Surg Br; 2009 Aug; 91(8):987-96. PubMed ID: 19651823
[TBL] [Abstract][Full Text] [Related]
13. Platelet rich plasma therapy: inflammatory molecules involved in tissue healing.
Galliera E; Corsi MM; Banfi G
J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):35S-42S. PubMed ID: 23648197
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet-rich plasma on ultraviolet b-induced skin wrinkles in nude mice.
Cho JM; Lee YH; Baek RM; Lee SW
J Plast Reconstr Aesthet Surg; 2011 Feb; 64(2):e31-9. PubMed ID: 20884308
[TBL] [Abstract][Full Text] [Related]
15. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism.
Dohan Ehrenfest DM; Bielecki T; Del Corso M; Inchingolo F; Sammartino G
J Biomed Mater Res A; 2010 Dec; 95(4):1280-2. PubMed ID: 20925082
[No Abstract] [Full Text] [Related]
16. Platelet-rich plasma therapy: origins and applications investigated.
Podd D
JAAPA; 2012 Jun; 25(6):44-9. PubMed ID: 22693884
[No Abstract] [Full Text] [Related]
17. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties.
El-Sharkawy H; Kantarci A; Deady J; Hasturk H; Liu H; Alshahat M; Van Dyke TE
J Periodontol; 2007 Apr; 78(4):661-9. PubMed ID: 17397313
[TBL] [Abstract][Full Text] [Related]
18. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery.
Wrotniak M; Bielecki T; Gaździk TS
Ortop Traumatol Rehabil; 2007; 9(3):227-38. PubMed ID: 17721419
[TBL] [Abstract][Full Text] [Related]
19. [The use of thrombocytic growth factors and collagen-containing substances in treatment of the chronic wounds of various etiology].
Obolenskiĭ VN; Ermolova DA
Khirurgiia (Mosk); 2012; (5):42-7. PubMed ID: 22810534
[TBL] [Abstract][Full Text] [Related]
20. How to optimize the preparation of leukocyte- and platelet-rich fibrin (L-PRF, Choukroun's technique) clots and membranes: introducing the PRF Box.
Dohan Ehrenfest DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Sep; 110(3):275-8; author reply 278-80. PubMed ID: 20727495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
